AACR Stories

The inaugural AACR Drug Discovery and Development (AACR D3) meeting will bring together the full continuum of stakeholders to launch a new era of cancer therapeutic innovation from bench to clinic.

Learn More

Unraveling the Role of ecDNA in Cancer

Researchers are shedding light on the multifaceted ways extrachromosomal DNA impacts cancer development and resistance to targeted therapies.

Learn More

Genetic Ancestry and Prostate Cancer

Ancestry-informed biology and precision treatment are helping to change the game for patients with prostate cancer.

Learn More

Fellows of the AACR Academy, Class of 2026

Twenty-four distinguished scientists whose major innovations have propelled progress against cancer elected as Fellows of the AACR Academy.

Learn More

VIEW ALL AACR STORIES

Boosting the Immune Response to Cancer

Decades of pioneering research led to a first-of-its-kind FDA approval for a new type of immunotherapy—tumor-infiltrating lymphocyte (TIL) therapy.

Learn More

Videos

Researching Ways to Intercept Cancer at Its Earliest StagesTumors are “born to be bad” with metastatic potential present from the start and spread to other organs when the original malignancy is the size of a poppy seed, explains Dr. Christina Curtis.

Moving the Dial Forward for Children with CancerAn AACR fellowship as a young pediatrician helped Michael Jensen, MD, become a physician-scientist, using clinical insights to inform the search for new cancer therapeutics in the laboratory.

AACR Grantee Studies a Rare Form of SarcomaSmall donations to the AACR added up to big support for promising new research by Madelyn Espinosa-Cotton, PhD, on a rare type of cancer that strikes teenagers and young adults.

AACR StoriesThe Faces & Voices Behind the Science

Videos